Introduction 7.622384
: 2.5079741
Ċ 1.0427654
In 9.83602
Ġrecent 3.8512166
Ġyears 0.31550422
, 0.36294904
Ġsubstantial 9.042402
Ġadvancements 5.188745
Ġhave 0.6441858
Ġbeen 0.09751796
Ġmade 0.07410226
Ġin 0.15856183
Ġthe 0.6161932
Ġtreatment 3.5289135
Ġof 0.14212534
Ġmelan 5.91716
oma 0.046877112
Ġ- 6.9067416
Ġa 2.010914
Ġhighly 3.7506866
Ġaggressive 1.1113888
Ġform 1.1998711
Ġof 0.0042646467
Ġskin 0.38641348
Ġcancer 0.017760204
. 0.6089091
ĠImm 9.031347
une 0.093646005
Ġcheckpoint 2.518509
Ġinhibitors 0.36759442
Ġand 3.5212688
Ġadj 5.3573513
u 0.66928434
vant 0.008033894
Ġtherapies 1.4818082
Ġhave 0.76157176
Ġemerged 4.6002927
Ġas 0.17749289
Ġgroundbreaking 8.452601
Ġtreatments 1.1863477
Ġthat 2.8203363
Ġoffer 4.1670923
Ġthe 2.4723055
Ġpotential 1.8448484
Ġfor 1.5670589
Ġlong 3.4695582
- 0.1477555
term 0.1803686
Ġremission 2.5822442
. 1.3369077
ĠThis 3.827514
Ġessay 6.8257594
Ġexplores 3.1120238
Ġthe 0.5736711
Ġimplications 5.0009785
Ġof 0.1571543
Ġthese 0.6098858
Ġtherapies 3.445659
Ġfor 0.5212665
Ġpatients 2.4351935
Ġat 4.5540314
Ġdifferent 6.1812487
Ġstages 0.03147629
Ġof 0.0764403
Ġmelan 2.7418113
oma 0.003496222
, 4.0567594
Ġfocusing 2.8318613
Ġon 0.19167107
Ġtheir 2.2638342
Ġimpact 2.9210947
Ġon 0.116383106
Ġimproving 7.812346
Ġsurvival 1.0268292
Ġrates 1.6774238
. 0.8243847
ĠTo 5.4495597
Ġfurther 3.9512398
Ġillustrate 3.2055628
Ġthese 2.8727458
Ġadvancements 3.9501116
, 0.18170784
Ġthe 1.7293849
Ġcase 5.468406
Ġof 0.31555474
ĠMr 5.862491
. 0.23349096
ĠB 4.6067753
, 2.2253397
Ġa 0.5096389
Ġmelan 4.031552
oma 0.008360208
Ġpatient 0.09245861
, 2.8960614
Ġwill 1.4390891
Ġbe 0.024947379
Ġused 2.7938275
Ġas 1.6578503
Ġan 0.68992573
Ġexample 0.15150031
. 0.3167316
Ċ 0.94729257
Body 12.465848
: 1.7616423
Ċ 0.93472254
The 3.28198
Ġintroduction 7.957384
Ġof 0.1523186
Ġimmune 3.1102836
Ġcheckpoint 0.033390008
Ġinhibitors 0.08861804
, 2.8302653
Ġsuch 1.7422724
Ġas 0.0034405354
Ġp 4.1553187
emb 0.20283602
rol 0.01419048
iz 0.00203281
um 0.002131783
ab 0.00065945653
Ġand 1.3941314
Ġn 3.9984958
iv 0.020453328
ol 0.15263882
um 0.004637405
ab 0.0029065718
, 0.142076
Ġmarks 6.9416003
Ġa 0.61616063
Ġsignificant 1.2267047
Ġshift 1.8906018
Ġin 0.1573483
Ġmelan 3.9688368
oma 0.0040880167
Ġtreatment 0.2976476
. 0.47294
ĠThese 1.860388
Ġinhibitors 4.639045
Ġtarget 2.414398
Ġspecific 3.591556
Ġcheckpoints 6.2415833
Ġon 2.662425
Ġimmune 3.2034256
Ġcells 0.34888175
, 1.4417039
Ġeffectively 5.192807
Ġblocking 1.5335208
Ġthe 0.97920024
Ġsignals 7.063171
Ġthat 0.5553474
Ġprevent 6.940754
ĠT 5.9933424
- 1.0515999
cells 1.2477759
Ġ( 3.7089577
a 2.390776
Ġtype 0.5611878
Ġof 0.002261408
Ġimmune 0.94170946
Ġcell 0.21623923
) 0.20892222
Ġfrom 0.058586776
Ġattacking 1.5106466
Ġcancer 1.992931
Ġcells 0.7188649
. 0.22265181
ĠAs 3.6463406
Ġa 0.4263942
Ġresult 0.051457305
, 0.07837433
Ġthe 2.145724
Ġbody 3.3780077
's 1.1932131
Ġimmune 0.93240386
Ġsystem 0.505945
Ġis 1.1848168
Ġreact 7.1875515
ivated 0.006497088
, 1.073351
Ġenhancing 6.4378514
Ġits 2.1080606
Ġability 0.40970773
Ġto 0.0058271294
Ġfight 0.91586673
Ġmelan 3.2545037
oma 0.0070138215
. 0.50561905
ĠSeveral 6.2365413
Ġstudies 2.4051554
Ġhave 0.26921114
Ġreported 4.1319394
Ġremarkable 6.1908927
Ġresponse 6.4384794
Ġrates 0.10296402
Ġto 2.4039178
Ġimmune 2.1104844
Ġcheckpoint 0.0045537506
Ġinhibitors 0.10279152
, 1.1866157
Ġwith 1.2017555
Ġa 2.4978416
Ġsubset 7.672999
Ġof 0.17157742
Ġpatients 0.19680181
Ġachieving 2.0695539
Ġdurable 5.7545476
Ġlong 4.215985
- 0.019543206
term 0.025445485
Ġremission 0.3555276
. 1.2047465
Ċ 1.5196142
Pat 4.9033318
ients 0.2047814
Ġwith 1.8504381
Ġadvanced 2.4771178
Ġor 4.0516124
Ġmetast 0.66757864
atic 0.0040899324
Ġmelan 0.23078504
oma 0.028390983
Ġhave 2.1559792
Ġparticularly 5.822225
Ġbenefited 1.7934638
Ġfrom 0.05791991
Ġimmune 1.5626826
Ġcheckpoint 0.0048330585
Ġinhibitors 0.1899352
. 0.77003956
ĠResearch 5.2469535
, 5.7618713
Ġincluding 2.5374115
Ġclinical 3.609058
Ġtrials 0.16483293
, 0.31277767
Ġconsistently 5.521194
Ġdemonstrate 3.2363598
Ġimproved 2.9329286
Ġoverall 3.9934306
Ġsurvival 0.10765674
Ġrates 0.7343576
Ġand 2.0380797
Ġprogression 5.1200347
- 0.15561853
free 0.0067687146
Ġsurvival 0.022014145
Ġin 2.708646
Ġpatients 0.21026903
Ġtreated 0.9214993
Ġwith 0.02090502
Ġthese 1.111523
Ġinhibitors 4.6951976
Ġcompared 3.2432983
Ġto 0.40631354
Ġtraditional 6.725108
Ġchemotherapy 2.5732791
. 1.0228529
ĠFor 4.0229163
Ġinstance 2.63603
, 0.004921943
Ġa 1.9696237
Ġstudy 1.7987065
Ġpublished 0.9508716
Ġin 0.09474549
Ġthe 0.7263723
ĠNew 2.165411
ĠEngland 0.013855243
ĠJournal 0.0052100397
Ġof 0.00624137
ĠMedicine 0.0020586126
Ġreported 2.8490455
Ġa 1.6346787
Ġmedian 2.9353604
Ġoverall 2.4669201
Ġsurvival 0.03332684
Ġof 0.57232904
Ġ72 5.4651046
. 0.54982084
1 2.5683584
Ġmonths 0.34471592
Ġin 1.4963894
Ġpatients 0.57811546
Ġreceiving 2.7745335
Ġp 1.1355768
emb 0.005256417
rol 0.006204365
iz 0.00011320953
um 2.8921473e-05
ab 9.0437854e-05
, 2.0151598
Ġcompared 1.312214
Ġto 0.07222064
Ġ16 5.4931865
. 0.056051325
0 3.49134
Ġmonths 0.10434484
Ġin 0.44666892
Ġthose 1.942281
Ġreceiving 0.33568358
Ġchemotherapy 2.049527
. 0.5221189
ĠThis 3.0178127
Ġpresents 10.680453
Ġa 0.6871052
Ġsignificant 1.917937
Ġadvancement 5.3948293
, 3.169334
Ġoffering 6.3143425
Ġnew 5.9777627
Ġhope 0.36726725
Ġto 1.8350855
Ġpatients 0.4342429
Ġwho 1.5641806
Ġwere 3.0531752
Ġpreviously 0.55916554
Ġfaced 4.6353426
Ġwith 0.0051429346
Ġlimited 5.566923
Ġtreatment 2.9790864
Ġoptions 0.0606466
Ġand 2.8327086
Ġpoor 3.9539158
Ġprog 1.5747794
nosis 0.14847519
. 0.15939097
Ċ 0.38941082
Furthermore 5.6466594
, 0.0015194152
Ġthe 2.1684542
Ġuse 3.1554463
Ġof 0.0036489991
Ġimmune 0.6585799
Ġcheckpoint 0.0030690623
Ġinhibitors 0.02372007
Ġas 4.5543
Ġadj 0.95105463
u 0.51544964
vant 0.0027884566
Ġtherapies 1.0455441
Ġin 3.0876734
Ġpatients 1.0069581
Ġwith 0.34528396
Ġhigh 5.050811
- 0.18230946
risk 0.6147763
Ġmelan 3.1905546
oma 0.08798227
Ġwho 5.380053
Ġhave 1.6491193
Ġundergone 3.2016897
Ġsurgical 3.1758199
Ġrese 0.5705305
ction 0.07100531
Ġhas 1.017561
Ġshown 3.5451422
Ġpromising 1.0066206
Ġresults 0.12517023
. 0.3851688
ĠAd 5.8119383
ju 0.07433901
vant 0.082597025
Ġtherapy 0.7223385
Ġis 1.6952692
Ġadministered 5.948352
Ġafter 2.7888784
Ġcur 7.5832453
ative 0.042610046
Ġsurgery 1.10989
Ġto 1.1666878
Ġeliminate 5.8748093
Ġany 4.103964
Ġremaining 2.5453143
Ġundet 10.63223
ected 0.24137384
Ġcancer 1.0620341
Ġcells 1.0146564
Ġand 2.4464989
Ġreduce 3.6971946
Ġthe 0.4698956
Ġrisk 0.94682604
Ġof 0.06820554
Ġrec 0.8521931
urrence 0.012473054
. 0.3168006
ĠFor 3.6767325
Ġinstance 1.5486536
, 0.0035450326
Ġa 1.1422285
Ġtrial 3.8523388
Ġinvestigating 5.713463
Ġthe 0.5458812
Ġuse 0.9201803
Ġof 0.0019354626
Ġp 1.4382399
emb 0.007932055
rol 0.0047048335
iz 8.507158e-05
um 7.219704e-05
ab 0.00031346135
Ġas 1.5846689
Ġadj 1.3674294
u 0.018042678
vant 0.00050015905
Ġtherapy 0.15315804
Ġfor 2.3599975
Ġpatients 0.56539935
Ġwith 0.38955152
Ġstage 3.68867
ĠIII 1.1927661
Ġmelan 1.5771395
oma 0.031826816
Ġdemonstrated 2.3274088
Ġa 0.89223963
Ġsignificantly 3.2457008
Ġincreased 2.9187348
Ġrec 4.009143
urrence 0.0062038237
- 1.0202726
free 0.0025176068
Ġsurvival 0.036904007
Ġamong 5.414721
Ġthe 3.2005808
Ġtreated 4.5005627
Ġgroup 0.8528571
Ġcompared 1.3069288
Ġto 0.043510977
Ġthose 2.0063486
Ġreceiving 1.612711
Ġplacebo 5.0669785
. 0.47181335
ĠThese 3.8904364
Ġfindings 1.4677954
Ġhighlight 2.8867948
Ġthe 0.2346028
Ġpotential 1.332896
Ġfor 1.2100399
Ġimmune 2.8322103
Ġcheckpoint 0.0029926563
Ġinhibitors 0.19314617
Ġto 0.45122445
Ġprovide 2.5643175
Ġlong 4.0184345
- 0.013838201
term 0.050379157
Ġremission 3.4230294
Ġand 2.7012873
Ġimprove 2.1782296
Ġsurvival 1.1908337
Ġrates 0.424817
Ġin 1.0176467
Ġearlier 10.185052
Ġstages 0.15008591
Ġof 0.014826078
Ġmelan 0.44661245
oma 0.0017079544
. 0.14577119
Ċ 0.15356445
The 2.6190808
Ġimplications 5.0073276
Ġof 0.15682703
Ġthese 1.2086283
Ġadvancements 2.4750843
Ġare 1.7574449
Ġprofound 3.403709
. 0.61502
ĠPatients 3.2855167
Ġdiagnosed 4.9453044
Ġwith 0.13802435
Ġmelan 1.0968986
oma 0.013292259
Ġat 3.134642
Ġvarious 4.2135525
Ġstages 0.01900799
Ġnow 6.4521403
Ġhave 0.3022751
Ġaccess 2.173611
Ġto 0.0020814266
Ġmore 3.7856948
Ġeffective 1.5742943
, 2.6079242
Ġtargeted 2.9174824
, 3.0785506
Ġand 0.17592861
Ġpersonalized 3.6066835
Ġtreatment 1.7727607
Ġoptions 0.549489
. 0.66307133
ĠMoreover 4.269325
, 0.0007550112
Ġimmune 5.6915936
Ġcheckpoint 0.0075586285
Ġinhibitors 0.06567483
Ġhave 1.6257105
Ġshown 3.3871992
Ġpotential 4.51558
Ġin 1.8412074
Ġextending 5.9519734
Ġsurvival 1.4543734
Ġrates 1.6009662
Ġeven 4.716687
Ġin 1.0384843
Ġstage 5.7442036
ĠIV 1.3512723
Ġmelan 0.4415377
oma 0.028777681
, 1.2090162
Ġhistorically 11.099889
Ġthe 1.5684131
Ġmost 0.23843198
Ġchallenging 3.7606564
Ġto 3.6822715
Ġtreat 0.10477431
. 0.27317318
ĠThis 2.478199
Ġremarkable 7.354465
Ġprogress 1.6456728
Ġnot 6.0701723
Ġonly 0.0024902422
Ġprolong 7.771834
s 0.025537383
Ġthe 1.6077298
Ġlives 1.295784
Ġof 0.010805021
Ġmelan 3.5998175
oma 0.012259792
Ġpatients 0.045228582
Ġbut 2.2804227
Ġalso 0.27909365
Ġimproves 2.1567614
Ġtheir 1.9277011
Ġquality 0.4851012
Ġof 0.011007853
Ġlife 0.0055515016
Ġby 3.8435495
Ġreducing 1.5782723
Ġthe 0.7878941
Ġburden 2.5603008
Ġof 0.08852914
Ġtraditional 7.912653
Ġtreatments 1.4833953
, 1.9347361
Ġsuch 0.8368912
Ġas 0.0066910647
Ġchemotherapy 0.8950414
. 0.78220946
Ċ 0.46128294
The 2.5043945
Ġcase 2.531472
Ġof 0.039976496
ĠMr 0.08689514
. 0.011420811
ĠB 0.0082367025
Ġexempl 5.481309
ifies 0.0063186847
Ġthe 0.75004494
Ġtransformative 4.9900928
Ġimpact 1.7661585
Ġof 0.34334886
Ġimmune 1.1680733
Ġcheckpoint 0.0029754387
Ġinhibitors 0.06242084
Ġon 1.7839569
Ġmelan 1.0661004
oma 0.0015594141
Ġtreatment 1.9988483
. 0.2877684
ĠMr 3.0369825
. 0.0026867897
ĠB 0.002322943
, 2.200427
Ġdiagnosed 3.9167123
Ġwith 0.40329173
Ġstage 1.0596528
ĠIV 0.89384764
Ġmelan 0.08270397
oma 0.0011497916
Ġand 4.8913727
Ġgiven 5.7976675
Ġa 2.0667284
Ġbleak 9.392445
Ġprog 0.01636717
nosis 0.0011398852
, 0.38725317
Ġcommenced 8.193155
Ġp 4.755391
emb 0.009974006
rol 0.0041568456
iz 0.00051960035
um 1.5567284e-05
ab 0.00018378951
Ġtreatment 0.64721876
. 2.6784008
ĠRem 7.3564086
ark 0.1828165
ably 0.0008886356
, 0.014272523
Ġhe 1.1758108
Ġexperienced 2.6365402
Ġtumor 7.0807033
Ġregression 0.65796787
, 2.08782
Ġleading 5.4642277
Ġto 0.23084743
Ġa 1.1510375
Ġcomplete 3.160845
Ġresponse 3.5086062
Ġand 2.2911072
Ġdurable 5.5606937
Ġlong 0.94638044
- 0.012524598
term 0.004532555
Ġremission 0.4591143
. 0.30963057
ĠThis 2.4584477
Ġexample 4.6532917
, 4.2258897
Ġamong 4.479447
Ġcountless 3.5119731
Ġothers 0.21268845
, 0.15263855
Ġdemonstrates 1.7444116
Ġthe 0.56173015
Ġpotential 1.7764251
Ġof 0.48816553
Ġimmune 0.52020216
Ġcheckpoint 0.002311713
Ġinhibitors 0.037510775
Ġin 1.6798731
Ġproviding 4.16649
Ġlife 4.8576307
- 0.026337493
al 4.4186654
tering 0.0022044186
Ġoutcomes 3.5122538
Ġfor 1.1693035
Ġmelan 1.9591017
oma 0.0040300833
Ġpatients 0.01995776
. 0.38696292
Ċ 0.394483
Conclusion 3.2908254
: 0.02499529
Ċ 0.5116132
The 1.7894329
Ġadvancements 5.0250945
Ġin 0.7455875
Ġmelan 1.2892985
oma 0.0029080068
Ġtreatment 0.1899404
Ġthrough 5.3737674
Ġthe 1.2042425
Ġuse 0.39211136
Ġof 0.0014157321
Ġimmune 0.17114863
Ġcheckpoint 0.0040351707
Ġinhibitors 0.012298225
Ġand 1.8896434
Ġadj 0.03842323
u 0.22342138
vant 0.0007827492
Ġtherapies 0.12387976
Ġhave 1.8023231
Ġrevolution 3.8941653
ized 0.01075857
Ġpatient 3.5185282
Ġcare 0.6756859
. 1.0765123
ĠThese 2.3203602
Ġtherapies 1.8558952
Ġoffer 1.8142682
Ġnewfound 9.844581
Ġhope 0.049586628
Ġfor 0.8977409
Ġmelan 2.6643107
oma 0.006264821
Ġpatients 0.12879264
Ġat 3.2947545
Ġvarious 1.7300329
Ġstages 0.011444504
, 3.1490965
Ġincluding 2.7811053
Ġthose 1.6253529
Ġwith 1.1916137
Ġadvanced 0.74444765
Ġor 0.98956525
Ġmetast 0.11133462
atic 0.0011129731
Ġdisease 0.90625316
. 0.18230282
ĠThe 2.1662447
Ġcase 4.208342
Ġof 0.03092384
ĠMr 0.04616939
. 0.0069863293
ĠB 0.0013302614
Ġexempl 1.7197703
ifies 0.01783611
Ġthe 0.3956803
Ġpotential 2.217564
Ġfor 1.4282982
Ġlong 6.5695086
- 0.008510844
term 0.02324601
Ġremission 0.7686824
Ġand 1.206288
Ġimproved 0.4633579
Ġchances 9.397561
Ġof 0.22922456
Ġsurvival 0.5195671
. 2.0596044
ĠAs 3.8463802
Ġresearch 6.2123675
Ġcontinues 0.6988868
Ġto 0.3048134
Ġenhance 7.5566745
Ġour 2.3012426
Ġunderstanding 0.089000285
Ġof 0.057007186
Ġthese 2.2829564
Ġtherapies 1.6547527
, 0.24796966
Ġit 2.8362446
Ġis 0.53821623
Ġcrucial 4.528362
Ġto 1.0099468
Ġensure 2.801071
Ġaccessibility 11.2439785
, 2.9071434
Ġaffordability 1.6575351
, 0.030206185
Ġand 0.07206048
Ġexpand 9.616235
Ġtheir 1.9221588
Ġuse 0.40400982
Ġto 2.0175445
Ġfurther 4.578925
Ġimprove 0.9123207
Ġthe 1.82966
Ġprog 3.337839
nosis 0.04991997
Ġand 1.7340454
Ġquality 1.0387136
Ġof 0.014606447
Ġlife 0.011563044
Ġfor 1.1402603
Ġmelan 1.5170093
oma 0.0024328204
Ġpatients 0.0152581
. 0.14714675
